University of Texas Health Science Center at Houston, USA
Zhiqiang An is Professor of Molecular Medicine, the Robert A. Welch Distinguished University Chair in Chemistry, and Director of the Texas Therapeutics Institute at the UT Health Science Center at Houston. His laboratory focuses on breast cancer antibody drug resistance mechanisms and cancer antibody drug discovery Previously, he was Director of Biologics Research at Merck Research Laboratories. Dr. An received his Ph.D. degree from the University of Kentucky and his postdoctoral training at the University of Wisconsin-Madison. He is elected fellow of Society for Industrial Microbiology and Biotechnology (SIMB) and the American Academy of Microbiology (ASM).